Alexander M. Seifalian, Professor of Nanotechnology and Regenerative Medicine worked at the Royal Free Hospital and University College London for over 26 years, during this time he spent a year at Harvard Medical School working on the development of vascular compliance graft and one year at Johns Hopkins Medical School looking at the treatment of liver cancer. He published more than 687 peer-reviewed research papers and registered 14 UK and International patents. On editorial boards of 45 journals. He supervised 121 PhD students, all successfully completed. He is currently the director of NRMC centre (co-founder of NanoRegMed Ltd, Nanoloom Ltd and Liberum Health Ltd) working on the commercialisation of his research.  During his career, he has led and managed many innovative projects with successful outcomes in terms of commercialisation and translation to patients. In 2007 he was awarded the top prize in the field for the development of nanomaterials and technologies for cardiovascular implants by Medical Future Innovation, and in 2009 he received a Business Innovation Award from UK Trade & Investment (UKTI). He was the European Life Science Awards’ Winner of Most Innovative New Product 2012 for the “synthetic trachea”. He won the Nanosmat Prize in 2013 and in 2016 he received the Distinguish Research Award in recognition of his outstanding work in regenerative medicine from Heals Healthy Life Extension Society.

• Nanotechnology
• Stem Cell Therapy
• Regenerative Medicine
• Surgery
• Nerve Regeneration
• Spinal Cord Injury

No content available to display!!!

No content available to display!!!

No content available to display!!!